Embera NeuroTherapeutics, Inc.
BioSpace1, 2031 Kings Highway
Shreveport, LA 71103
BioSpace1, 2031 Kings Highway
Shreveport, LA 71103
Media Requests
Embera NeuroTherapeutics, Inc.
BioSpace1, Suite 230
2031 Kings Highway
Shreveport, LA 71103
Phone: (318) 213-0198
Fax: (318) 213-0195
Contact Us Online
Embera Press
Embera Board Director Dr. Franz Hefti is Keynote Speaker at Shreveport Biotech Meeting
"Franz Hefti compares Shreveport's biotechnology and pharmaceutical industry to the local movie industry during the Biomedical Research Foundation of Northwest Louisiana's annual meeting Thursday."
June 13, 2008, The Times (http://www.shreveporttimes.com)
Locals to benefit from cocaine addiction study
"After years of watching rats thump a lever to get their fix of cocaine, a local researcher has found a way to make them choose to stop."
January 9, 2008, The Times (http://www.shreveporttimes.com)
Embera Initiates Cocaine Addiction Study at LSU Health Sciences Center
"Embera NeuroTherapeutics, Inc. announced the commencement of the first clinical trial evaluating its patent-pending drug combination for the treatment of cocaine addiction. The study is being conducted at the LSU Health Sciences Center's Psychopharmacology Research Clinic in Shreveport under the supervision of Dr. Anita Kablinger. This will be the first placebo-controlled study to validate the science behind Embera's combination drug product."
Red River Radio Interview (MP3, 2:13)
December 21, 2007
"Embera NeuroTherapeutics, Inc. announced today that Charles O'Brien, MD, PhD, Kathleen Brady, MD, PhD and Rajita Sinha, PhD have joined the company's Scientific Advisory Board. Dr. Nicholas E. Goeders, Embera Chief Scientific Officer, said 'It is exciting to have these three experts in the field of addiction research as members of our Scientific Advisory Board. Their vast knowledge and experience will be invaluable in the design and execution of our clinical trials on addiction.'"
May 4, 2007
Drug Research Comes In Many Forms
"...It breaks the ability of the triggers in the environment that stimulates cravings and relapses...."
February 22, 2007 - KTRE-TV (http://www.ktre.com)
LSUHSC professor secures $800,000 for drug research
"Nicholas Goeders has always had interest in researching medical treatment for addictions. Now he'll have the money, too..."
February 7, 2007, The Times (http://www.shreveporttimes.com)
Embera NeuroTherapeutics, Inc. Closes Series A Funding, Starting FDA Trial Process
"Embera NeuroTherapeutics, Inc., a start-up company developing novel treatments for a broad range of addictions, as well as other neuropsychiatric disorders, has secured over $800,000 of Series A financing that will help the company move its novel combinational drug into Phase 1b FDA trials."
February 6, 2007
Addiction In The News
New Weapons Against Cocaine Addiction
By Peter Sergo, Scientific American
"Many people still chalk up the destructive behavior of a drug addict to a lack of willpower or weakness of character. To a neuroscientist, however, drug addiction is a psychiatric illness that develops when the repeated use of narcotics disrupts brain chemistry. Such a chemical disturbance cries out for a chemical solution - that is, a drug treatment..."
April, 2008
Potential New Way to Kick a Coke Habit: Mixing Tranquilizers with Hormone Blockers
By Aaron Rowe, Wired Blog Network
"By taking a common tranquilizer along with a medicine that slows the production of stress hormones, cocaine addicts may be able to fight their addiction in an impressive new way..."
January 04, 2008
Damage to the Insula Disrupts Addiction to Cigarette Smoking
By Nasir H. Naqvi, et al. Science 315, 531 (2007)
"We found that smokers with brain damage involving the insula, a region implicated in conscious urges, were more likey..."
January 26, 2007